Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway-Reference-Cited by-同舟云学术

Phosphodiesterase (PDE) inhibitor torbafylline (HWA 448) attenuates burn-induced rat skeletal muscle proteolysis through the PDE4/cAMP/EPAC/PI3K/Akt pathway

Published:2014-08 Issue:1-2 Volume:393 Page:152-163
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Joshi Rashika,Kadeer Nijiati,Sheriff Sulaiman,Friend Lou Ann,James J. Howard,Balasubramaniam Ambikaipakan

Funder

Shriners Hospital for Children

Department of Veteran Affairs Grant

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference66 articles.

1. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children;Aili Low;Burns,2001

2. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion;Almahariq;Mol. Pharmacol.,2013

3. Torbafylline (HWA 448) inhibits skeletal muscle proteolysis in burned rats (Abstract);Balasubramaniam;J. Burn Care Rehabil.,2009

4. Ghrelin inhibits skeletal muscle protein breakdown in rats with thermal injury through normalizing elevated expression of E3 ubiquitin ligases, MuRF1 and MAFbx;Balasubramaniam;Am. J. Physiol. Regul. Integr. Comp. Physiol.,2009

5. Pentoxifylline inhibits Ca2+-dependent and ATP proteasome-dependent proteolysis in skeletal muscle from acutely diabetic rats;Baviera;Am. J. Physiol. Endocrinol. Metab.,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Therapeutic Strategies for Skeletal Muscle Atrophy;Antioxidants;2022-12-26

2. A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment;Neurotherapeutics;2021-10

3. Polyphenols and Their Effects on Muscle Atrophy and Muscle Health;Molecules;2021-08-12

4. Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors;Life Sciences;2021-08

5. Drugs for the Treatment of Muscle Atrophy;Background and Management of Muscular Atrophy;2021-03-03